A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.
A2 Biotherapeutics was founded in 2018 by Alexander Kamb.
1282 health care and life sciences companies are in the directory, 159 of them in the same 51-100 employee range and 48 based in Greater Los Angeles Area.
A2 Biotherapeutics may be growing as indicated by the company's active participation in the American Society of Clinical Oncology (ASCO) Annual Meeting, where they highlighted the progress of their CAR T clinical programs through three poster presentations. This suggests ongoing research and development efforts, which are critical for growth in the biotechnology industry. Additionally, the mention of a C-Suite shuffle implies organizational changes that could be associated with expansion or scaling efforts. The focus on CAR T-cell clinical programs also indicates a specialization in a cutting-edge area of biotechnology, which could position the company for growth within the health care and life science industries.
“A2 is dedicated to advancing cancer treatment through pioneering cell therapy. Our T cells target solid tumors with precision, transforming the future of medicine.” a2bio.com
A2 Biotherapeutics is a biotechnology company based in Greater Los Angeles Area, with 51-100 employees, founded in 2018. Its founder is Alexander Kamb and it has raised $190.5 million over 4 rounds.
51-100 employees · 4basebio.com
11-50 employees · acernatec.com
11-50 employees · alxoncology.com
1-10 employees · accugenomics.com
1-10 employees · adientmedical.com
501-1,000 employees · apcerls.com
51-100 employees · abingdonhealth.com
51-100 employees · acmeca.com
51-100 employees · aoporphan.com
51-100 employees · 1859.ai
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.